Dr. Shih-Yin Tsai (National University of Singapore, Singapore) showed that eukaryotic translation initiation factor 4E (eIF4E) binding protein 1 (EIF4EBP1 or 4E-BP1) activation proved to be beneficial in sarcopenia, where the proteostasis is disrupted. Here, EIF4EBP1 is linked to sarcopenia.